CASP9 and neoplasm: Tumor cell lysates revealed activation of pro-apoptotic proteins (BAX and cleaved caspase 9) and reduction of anti-apoptotic proteins (MCL-1, BCL-XL, p-BAD) in tumors of the ponatinib-treated mice compared to tumors of the vehicle-treated mice (Fig. 6e).